Portfolio company
The Akkermansia Company
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
The company develops and sells pasteurised gut microbiome supplements to consumers and health professionals for weight management and metabolic health.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Gut Wealth
This company manufactures digestive health supplements, including postbiotic capsules and liquid sachets, for individuals suffering from irritable bowel syndrome and digestive discomfort.
GutCRINE
This company develops microbiome-derived pharmabiotics to treat metabolic and age-related disorders including obesity and type-2 diabetes for patients with chronic diseases.
InnerBuddies
This company provides microbiome analysis kits and nutritional advice for consumers and corporate health partners seeking to improve gut health and well-being.
Ousia Pharma
This biotechnology company develops peptide-drug conjugates to treat obesity and cardiometabolic diseases for patients requiring improved metabolic health and weight regulation.
SoWell Health
This company provides metabolic health diagnostic kits and nutritional supplements for individuals managing weight loss treatments and metabolic conditions.
Metabolize
This company develops dietary supplements for individuals managing weight after discontinuing or cycling off GLP-1 medications to help maintain muscle and regulate appetite.
Lembas
This company develops bioactive peptide ingredients for food and supplement manufacturers to help consumers manage weight through natural hormone regulation.
Metabogen
This company develops microbiome-based probiotics and pharmaceuticals for the probiotic and pharmaceutical industries to treat various health conditions.
